C. Gregory Arnold
Vice President of Manufacturing

Mr. Arnold has significant transdermal pharmaceutical experience in process development and manufacturing with the transdermal dosage form. Most recently he was Vice President of Manufacturing at Vyteris where an iontophoretic transdermal product was brought to market. Previously, he was with Watson Pharmaceuticals (formally TheraTech) where he held the position of Executive Director, Transdermal Product Development directing the manufacturing process development and facility validation of two commercial transdermal products.

Earlier, he was Vice President for Cygnus Therapeutic Systems where he directed the manufacturing scale-up and facility validation for the commercial introduction of a transdermal product. He also held the position of Manager of Product Development where he managed the process development and validation for the commercial launch of two transdermal products. He has also been responsible for the packaging operations at Ciba Geigy and Sterling Drug.

Mr. Arnold received a B.S. in Industrial Engineering from Pennsylvania State University.